Chu‐Xin Li
Impact in
- Biomedical Engineering top 0.2%
- Nanoplatforms for cancer theranostics
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 40
-
- Cancer Research and Treatments 5
In The Last Decade
Chu‐Xin Li
52 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Biomedical Engineering 4.8k
- Biomaterials 1.4k
- Materials Chemistry 2.4k
- Biotechnology 358
- Cancer Research 580
Countries citing papers authored by Chu‐Xin Li
This map shows the geographic impact of Chu‐Xin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chu‐Xin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chu‐Xin Li more than expected).
Fields of papers citing papers by Chu‐Xin Li
This network shows the impact of papers produced by Chu‐Xin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chu‐Xin Li. The network helps show where Chu‐Xin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chu‐Xin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2022 | 30 | |
| 3 | 2022 | 7 | |
| 4 | 2021 | 25 | |
| 5 | 2021 | 57 | |
| 6 | 2021 | 27 | |
| 7 | 2020 | 57 | |
| 8 | 2020 | 23 | |
| 9 | 2020 | 39 | |
| 10 | 2019 | 32 | |
| 11 | 2019 | 176 | |
| 12 | 2019 | 75 | |
| 13 | 2019 | 110 | |
| 14 | 2019 | 169 | |
| 15 | 2019 | 98 | |
| 16 | 2019 | 93 | |
| 17 | Engineered Bacterial Bioreactor for Tumor Therapy via Fenton‐Like Reaction with Localized H2O2 Generation Hit paper breakdown → | 2019 | 341 |
| 18 | 2018 | 90 | |
| 19 | 2018 | 30 | |
| 20 | An Adenosine Triphosphate-Responsive Autocatalytic Fenton Nanoparticle for Tumor Ablation with Self-Supplied H2O2 and Acceleration of Fe(III)/Fe(II) Conversion Hit paper breakdown → | 2018 | 537 |
About Chu‐Xin Li
Chu‐Xin Li is a scholar working on Biomedical Engineering, Biotechnology, Immunology, Cancer Research and Biomaterials, having authored 52 papers that have together received 6.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (40 papers), Advanced Nanomaterials in Catalysis (8 papers), Immunotherapy and Immune Responses (7 papers), Photodynamic Therapy Research Studies (7 papers), Immune cells in cancer (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Cancer Research and Treatments (5 papers). The work is most often cited by research in Biomedical Engineering (4.8k citations), Biomaterials (1.4k citations), Materials Chemistry (2.4k citations), Biotechnology (358 citations) and Cancer Research (580 citations). Chu‐Xin Li has collaborated with scholars based in China and Maldives. Frequent co-authors include Xian‐Zheng Zhang, Diwei Zheng, Shuangshuang Wan, Lu Zhang, Jin‐Xuan Fan, Wenlong Liu, Lu Xu, Qi Lei, Bo‐Ru Xie and Zushun Xu. Their work appears in journals such as Advanced Materials, ACS Nano, Biomaterials, Nano Letters and Small.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.